STOCK TITAN

[144] Penumbra, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Penumbra, Inc. submitted a Form 144 reporting a proposed sale of 2,000 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $500,000. The filing lists 38,999,129 shares outstanding and specifies the approximate sale date as 08/13/2025 on the NYSE. The notice shows no securities sold in the past three months under the provided "Nothing to Report" entry.

The 2,000 shares to be sold match earlier restricted stock acquisitions recorded in the filing: 338 shares on 12/16/2020, 612 on 11/15/2022, 726 on 12/16/2022, and 324 on 03/15/2024, totaling 2,000 shares. The filer makes the required representation regarding material nonpublic information and mentions Rule 10b5-1 instructions if applicable.

Penumbra, Inc. ha presentato un Modulo 144 segnalando una proposta di vendita di 2,000 azioni ordinarie tramite Morgan Stanley Smith Barney LLC con un valore di mercato complessivo di $500,000. Il deposito indica 38,999,129 azioni in circolazione e specifica la data approssimativa di vendita come 08/13/2025 sulla NYSE. La comunicazione mostra nessun titolo venduto nei tre mesi precedenti con la voce riportata "Nothing to Report".

Le 2,000 azioni da vendere corrispondono ad acquisizioni di restricted stock registrate in precedenza nel deposito: 338 azioni il 12/16/2020, 612 il 11/15/2022, 726 il 12/16/2022 e 324 il 03/15/2024, per un totale di 2,000 azioni. Il dichiarante rilascia la dichiarazione richiesta riguardo a informazioni materiali non pubbliche e cita, se applicabili, le istruzioni previste dalla Rule 10b5-1.

Penumbra, Inc. presentó un Formulario 144 notificando una propuesta de venta de 2,000 acciones comunes a través de Morgan Stanley Smith Barney LLC con un valor de mercado agregado de $500,000. La presentación indica 38,999,129 acciones en circulación y especifica la fecha aproximada de venta como 08/13/2025 en la NYSE. El aviso muestra ningún valor vendido en los últimos tres meses bajo la entrada "Nothing to Report".

Las 2,000 acciones a vender coinciden con adquisiciones previas de acciones restringidas registradas en la presentación: 338 el 12/16/2020, 612 el 11/15/2022, 726 el 12/16/2022 y 324 el 03/15/2024, que suman 2,000 acciones. El declarante realiza la representación requerida respecto a información material no pública y menciona las instrucciones Rule 10b5-1, si proceden.

Penumbra, Inc.는 Form 144를 제출하여 Morgan Stanley Smith Barney LLC를 통해 2,000 보통주 매도를 제안했으며, 총 시가총액 $500,000로 보고했습니다. 제출서에는 유통 주식 수를 38,999,129주로 기재하고 있으며, NYSE에서의 대략적인 매도 예정일을 08/13/2025로 명시했습니다. 통지서에는 제공된 "Nothing to Report" 항목에 따라 최근 3개월간 매도된 증권 없음으로 표시되어 있습니다.

매도 예정인 2,000주는 제출서에 기록된 이전 제한주 취득과 일치합니다: 338주(12/16/2020), 612주(11/15/2022), 726주(12/16/2022)324주(03/15/2024), 합계 2,000주. 제출인은 중요 비공개 정보에 관한 필수 진술을 했으며, 해당되는 경우 Rule 10b5-1 지침을 언급했습니다.

Penumbra, Inc. a déposé un formulaire 144 signalant une proposition de vente de 2,000 actions ordinaires par l'intermédiaire de Morgan Stanley Smith Barney LLC, pour un valeur de marché totale de $500,000. Le dossier indique 38,999,129 actions en circulation et précise la date approximative de vente au 08/13/2025 sur le NYSE. L'avis indique aucun titre vendu au cours des trois derniers mois sous l'entrée "Nothing to Report".

Les 2,000 actions à vendre correspondent à des acquisitions antérieures d'actions restreintes consignées dans le dossier : 338 le 12/16/2020, 612 le 11/15/2022, 726 le 12/16/2022 et 324 le 03/15/2024, soit au total 2,000 actions. Le déclarant effectue la représentation requise concernant les informations matérielles non publiques et mentionne, le cas échéant, les instructions Rule 10b5-1.

Penumbra, Inc. hat ein Formular 144 eingereicht, das einen geplanten Verkauf von 2,000 Stammaktien über Morgan Stanley Smith Barney LLC mit einem gesamten Marktwert von $500,000 meldet. Die Einreichung listet 38,999,129 ausstehende Aktien und nennt das ungefähre Verkaufsdatum als 08/13/2025 an der NYSE. Die Mitteilung weist unter dem Eintrag "Nothing to Report" keine Wertpapiere, die in den letzten drei Monaten verkauft wurden aus.

Die zu veräußernden 2,000 Aktien entsprechen früheren Aufzeichnungen über Restricted-Stock-Akquisitionen in der Einreichung: 338 am 12/16/2020, 612 am 11/15/2022, 726 am 12/16/2022 und 324 am 03/15/2024, insgesamt 2,000 Aktien. Der Einreicher gibt die erforderliche Erklärung in Bezug auf wesentliche nichtöffentliche Informationen ab und erwähnt gegebenenfalls Anweisungen gemäß Rule 10b5-1.

Positive
  • Proposed sale fully specified: 2,000 common shares with $500,000 aggregate market value and broker identified as Morgan Stanley Smith Barney LLC
  • Acquisition history disclosed: all 2,000 shares were recorded as restricted stock on documented dates totaling the amount offered for sale
  • No recent sales reported: the filing shows "Nothing to Report" for sales during the past three months
Negative
  • Issuer contact fields are blank in the provided excerpt: key issuer address/phone/name entries are not populated in this content

Insights

Small, transparent insider sale disclosed; not likely market-moving.

The Form 144 notifies the market of a planned sale of 2,000 common shares via Morgan Stanley Smith Barney at an aggregate value of $500,000. The filing documents that these shares were acquired as restricted stock across four grant dates and that no sales occurred in the prior three months. Given the listed 38,999,129 shares outstanding, the position disclosed is small relative to the share base and therefore unlikely to be materially impactful to valuation.

Form 144 provides required disclosure and acquisition provenance; procedural completeness is mixed.

The filing supplies broker details and acquisition dates showing the securities were granted as restricted stock, which is relevant for Rule 144 eligibility. The filer also includes the statutory representation about nonpublic material information and notes Rule 10b5-1 plan consideration. However, several issuer contact fields in the excerpt are not populated, which reduces the filing's standalone completeness for third-party verification.

Penumbra, Inc. ha presentato un Modulo 144 segnalando una proposta di vendita di 2,000 azioni ordinarie tramite Morgan Stanley Smith Barney LLC con un valore di mercato complessivo di $500,000. Il deposito indica 38,999,129 azioni in circolazione e specifica la data approssimativa di vendita come 08/13/2025 sulla NYSE. La comunicazione mostra nessun titolo venduto nei tre mesi precedenti con la voce riportata "Nothing to Report".

Le 2,000 azioni da vendere corrispondono ad acquisizioni di restricted stock registrate in precedenza nel deposito: 338 azioni il 12/16/2020, 612 il 11/15/2022, 726 il 12/16/2022 e 324 il 03/15/2024, per un totale di 2,000 azioni. Il dichiarante rilascia la dichiarazione richiesta riguardo a informazioni materiali non pubbliche e cita, se applicabili, le istruzioni previste dalla Rule 10b5-1.

Penumbra, Inc. presentó un Formulario 144 notificando una propuesta de venta de 2,000 acciones comunes a través de Morgan Stanley Smith Barney LLC con un valor de mercado agregado de $500,000. La presentación indica 38,999,129 acciones en circulación y especifica la fecha aproximada de venta como 08/13/2025 en la NYSE. El aviso muestra ningún valor vendido en los últimos tres meses bajo la entrada "Nothing to Report".

Las 2,000 acciones a vender coinciden con adquisiciones previas de acciones restringidas registradas en la presentación: 338 el 12/16/2020, 612 el 11/15/2022, 726 el 12/16/2022 y 324 el 03/15/2024, que suman 2,000 acciones. El declarante realiza la representación requerida respecto a información material no pública y menciona las instrucciones Rule 10b5-1, si proceden.

Penumbra, Inc.는 Form 144를 제출하여 Morgan Stanley Smith Barney LLC를 통해 2,000 보통주 매도를 제안했으며, 총 시가총액 $500,000로 보고했습니다. 제출서에는 유통 주식 수를 38,999,129주로 기재하고 있으며, NYSE에서의 대략적인 매도 예정일을 08/13/2025로 명시했습니다. 통지서에는 제공된 "Nothing to Report" 항목에 따라 최근 3개월간 매도된 증권 없음으로 표시되어 있습니다.

매도 예정인 2,000주는 제출서에 기록된 이전 제한주 취득과 일치합니다: 338주(12/16/2020), 612주(11/15/2022), 726주(12/16/2022)324주(03/15/2024), 합계 2,000주. 제출인은 중요 비공개 정보에 관한 필수 진술을 했으며, 해당되는 경우 Rule 10b5-1 지침을 언급했습니다.

Penumbra, Inc. a déposé un formulaire 144 signalant une proposition de vente de 2,000 actions ordinaires par l'intermédiaire de Morgan Stanley Smith Barney LLC, pour un valeur de marché totale de $500,000. Le dossier indique 38,999,129 actions en circulation et précise la date approximative de vente au 08/13/2025 sur le NYSE. L'avis indique aucun titre vendu au cours des trois derniers mois sous l'entrée "Nothing to Report".

Les 2,000 actions à vendre correspondent à des acquisitions antérieures d'actions restreintes consignées dans le dossier : 338 le 12/16/2020, 612 le 11/15/2022, 726 le 12/16/2022 et 324 le 03/15/2024, soit au total 2,000 actions. Le déclarant effectue la représentation requise concernant les informations matérielles non publiques et mentionne, le cas échéant, les instructions Rule 10b5-1.

Penumbra, Inc. hat ein Formular 144 eingereicht, das einen geplanten Verkauf von 2,000 Stammaktien über Morgan Stanley Smith Barney LLC mit einem gesamten Marktwert von $500,000 meldet. Die Einreichung listet 38,999,129 ausstehende Aktien und nennt das ungefähre Verkaufsdatum als 08/13/2025 an der NYSE. Die Mitteilung weist unter dem Eintrag "Nothing to Report" keine Wertpapiere, die in den letzten drei Monaten verkauft wurden aus.

Die zu veräußernden 2,000 Aktien entsprechen früheren Aufzeichnungen über Restricted-Stock-Akquisitionen in der Einreichung: 338 am 12/16/2020, 612 am 11/15/2022, 726 am 12/16/2022 und 324 am 03/15/2024, insgesamt 2,000 Aktien. Der Einreicher gibt die erforderliche Erklärung in Bezug auf wesentliche nichtöffentliche Informationen ab und erwähnt gegebenenfalls Anweisungen gemäß Rule 10b5-1.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What shares does Penumbra (PEN) plan to sell under this Form 144?

2,000 common shares via Morgan Stanley Smith Barney LLC with an aggregate market value of $500,000

When is the approximate date of the proposed sale listed on the Form 144?

08/13/2025 is shown as the approximate date of sale

On which exchange will the shares be sold?

NYSE is listed as the securities exchange for the proposed sale

How were the 2,000 shares acquired according to the filing?

They were acquired as restricted stock: 338 on 12/16/2020, 612 on 11/15/2022, 726 on 12/16/2022, and 324 on 03/15/2024

Were any securities sold by the filer in the past three months?

Nothing to Report is entered for securities sold during the past three months
Penumbra Inc

NYSE:PEN

PEN Rankings

PEN Latest News

PEN Latest SEC Filings

PEN Stock Data

9.69B
37.58M
3.64%
91.28%
4.69%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
ALAMEDA